Switching from eltrombopag to hetrombopag in patients with primary immune thrombocytopenia: a post-hoc analysis of a multicenter, randomized phase III trial.
Mei H, Liu X, Li Y, Zhou H, Feng Y, Gao G, Cheng P, Huang R, Yang L, Hu J, Hou M, Yao Y, Liu L, Wang Y, Wu D, Shen X, Jin J, Luo J, Zeng Y, Zhou X, Xia R, Jiang Z, Bai Y, Niu T, Yang R, Hu Y.
Mei H, et al. Among authors: hou m.
Ann Hematol. 2024 Jun 6. doi: 10.1007/s00277-024-05826-5. Online ahead of print.
Ann Hematol. 2024.
PMID: 38842566